These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21984127)

  • 21. Thrombospondin-1 Is a Major Activator of TGF-β Signaling in Recessive Dystrophic Epidermolysis Bullosa Fibroblasts.
    Atanasova VS; Russell RJ; Webster TG; Cao Q; Agarwal P; Lim YZ; Krishnan S; Fuentes I; Guttmann-Gruber C; McGrath JA; Salas-Alanis JC; Fertala A; South AP
    J Invest Dermatol; 2019 Jul; 139(7):1497-1505.e5. PubMed ID: 30684555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloid-related proteins-8 and -14 are expressed but dispensable in the pathogenesis of experimental epidermolysis bullosa acquisita and bullous pemphigoid.
    Akbarzadeh R; Yu X; Vogl T; Ludwig RJ; Schmidt E; Zillikens D; Petersen F
    J Dermatol Sci; 2016 Mar; 81(3):165-72. PubMed ID: 26692467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice.
    Sitaru C; Chiriac MT; Mihai S; Büning J; Gebert A; Ishiko A; Zillikens D
    J Immunol; 2006 Sep; 177(5):3461-8. PubMed ID: 16920988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of quantitative trait loci in experimental epidermolysis bullosa acquisita.
    Ludwig RJ; Müller S; Marques Ad; Recke A; Schmidt E; Zillikens D; Möller S; Ibrahim SM
    J Invest Dermatol; 2012 May; 132(5):1409-15. PubMed ID: 22297639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermolysis bullosa acquisita.
    Kim JH; Kim SC
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1204-13. PubMed ID: 23368767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
    Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
    Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flightless I is a key regulator of the fibroproliferative process in hypertrophic scarring and a target for a novel antiscarring therapy.
    Cameron AM; Turner CT; Adams DH; Jackson JE; Melville E; Arkell RM; Anderson PJ; Cowin AJ
    Br J Dermatol; 2016 Apr; 174(4):786-94. PubMed ID: 26521845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal Damage Induces Th1 Polarization and Defines the Site of Inflammation in Murine Epidermolysis Bullosa Acquisita.
    Niebuhr M; Bieber K; Banczyk D; Maass S; Klein S; Becker M; Ludwig R; Zillikens D; Westermann J; Kalies K
    J Invest Dermatol; 2020 Sep; 140(9):1713-1722.e9. PubMed ID: 32057838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
    J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raloxifene and n-Acetylcysteine Ameliorate TGF-Signalling in Fibroblasts from Patients with Recessive Dominant Epidermolysis Bullosa.
    Aguado T; García M; García A; Ferrer-Mayorga G; Martínez-Santamaría L; Del Río M; Botella LM; Sánchez-Puelles JM
    Cells; 2020 Sep; 9(9):. PubMed ID: 32947957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caspase-1-independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules.
    Sadeghi H; Lockmann A; Hund AC; Samavedam UK; Pipi E; Vafia K; Hauenschild E; Kalies K; Pas HH; Jonkman MF; Iwata H; Recke A; Schön MP; Zillikens D; Schmidt E; Ludwig RJ
    J Immunol; 2015 Apr; 194(8):3656-63. PubMed ID: 25795756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity.
    Odorisio T; Di Salvio M; Orecchia A; Di Zenzo G; Piccinni E; Cianfarani F; Travaglione A; Uva P; Bellei B; Conti A; Zambruno G; Castiglia D
    Hum Mol Genet; 2014 Aug; 23(15):3907-22. PubMed ID: 24599399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features and diagnosis of epidermolysis bullosa acquisita.
    Vorobyev A; Ludwig RJ; Schmidt E
    Expert Rev Clin Immunol; 2017 Feb; 13(2):157-169. PubMed ID: 27580464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiosensitive Hematopoietic Cells Determine the Extent of Skin Inflammation in Experimental Epidermolysis Bullosa Acquisita.
    Iwata H; Witte M; Samavedam UK; Gupta Y; Shimizu A; Ishiko A; Schröder T; Seeger K; Dahlke M; Rades D; Zillikens D; Ludwig RJ
    J Immunol; 2015 Sep; 195(5):1945-54. PubMed ID: 26202985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing the level of cytoskeletal protein Flightless I reduces adhesion formation in a murine digital flexor tendon model.
    Jackson JE; Kopecki Z; Anderson PJ; Cowin AJ
    J Orthop Surg Res; 2020 Aug; 15(1):362. PubMed ID: 32854733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcitriol Treatment Ameliorates Inflammation and Blistering in Mouse Models of Epidermolysis Bullosa Acquisita.
    Tukaj S; Bieber K; Witte M; Ghorbanalipoor S; Schmidt E; Zillikens D; Ludwig RJ; Kasperkiewicz M
    J Invest Dermatol; 2018 Feb; 138(2):301-309. PubMed ID: 28942362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast-specific upregulation of Flightless I impairs wound healing.
    Turner CT; Waters JM; Jackson JE; Arkell RM; Cowin AJ
    Exp Dermatol; 2015 Sep; 24(9):692-7. PubMed ID: 25959103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy.
    Fritsch A; Loeckermann S; Kern JS; Braun A; Bösl MR; Bley TA; Schumann H; von Elverfeldt D; Paul D; Erlacher M; Berens von Rautenfeld D; Hausser I; Fässler R; Bruckner-Tuderman L
    J Clin Invest; 2008 May; 118(5):1669-79. PubMed ID: 18382769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen.
    Sitaru C; Mihai S; Otto C; Chiriac MT; Hausser I; Dotterweich B; Saito H; Rose C; Ishiko A; Zillikens D
    J Clin Invest; 2005 Apr; 115(4):870-8. PubMed ID: 15841176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita.
    Ludwig RJ; Recke A; Bieber K; Müller S; Marques Ade C; Banczyk D; Hirose M; Kasperkiewicz M; Ishii N; Schmidt E; Westermann J; Zillikens D; Ibrahim SM
    J Invest Dermatol; 2011 Jan; 131(1):167-76. PubMed ID: 20720563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.